The Traderszone Network

Published in TZ Latest News 28 January, 2016 by The TZ Newswire Staff

ABLYNX TO RECEIVE EU8 MILLION MILESTONE AS BOEHRINGER INGELHEIM STARTS FIRST PATIENT STUDY WITH A BI-SPECIFIC NANOBODY IN ONCOLOGY